164
Participants
Start Date
December 4, 2024
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Daridorexant
Daridorexant will be taken orally, once daily in the evening as indicated by investigator.
Placebo
Placebo will be taken orally, once daily in the evening as indicated by investigator.
Inje University Ilsan Paik Hospital, Ilsan
Seoul National University Bundang Hospital, Seongnam-si
The Catholic University of Korea, ST. Vincent's Hospital, Suwon
Gachon University Gil Medical Center, Incheon
Catholic Kwandong University International St. Mary'S Hospital, Incheon
Wonju Severance Christian Hospital, Wŏnju
Soon Shun Hyang University Cheonan Hospital, Cheonan
Chungnam National University Hospital, Daejeon
Keimyung University Dongsan Medical Center, Daegu
Inje University Busan Paik Hospital, Busan
Pusan National University Yangsan Hospital, Busan
Chonnam National University Hospital, Gwangju
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Kyung Hee University Hospital At Gangdong, Seoul
Asan Medical Center, Seoul
Ewha Womans University Medical Center, Seoul
Nxera Pharma Korea Co., Ltd.
INDUSTRY